The U.S. Food and Drug Administration’s (“FDA” or “the Agency”) Center for Devices and Radiological Health (“CDRH”) recently announced the launch of its Total Product Life Cycle Advisory Program (“TAP”) Pilot. The first phase of this voluntary initiative, called TAP Pilot Soft Launch, will be conducted during fiscal year (“FY”) 2023 with enrollment beginning on
Latest Post
More Posts
FDA Issues Final Clinical Decision Support Software Guidance
Brian Burgess to Speak on Emerging Legal Issues and Trends for Interchangeable Biosimilars at FDLI Annual Conference
Clinical Trial Diversity Planning for Sponsors: What to Know About FDA’s Recent Draft Guidance
Subscribe: Subscribe via RSS
Firm/Org